Role of FDG-PET for the treatment strategy of malignant lymphoma

Research output: Contribution to journalReview article

Abstract

FDG-PET is increasingly being used for assessment of the staging, for evaluating the response to treatment, and for monitoring the reactions to therapy in malignant lymphoma. This review will highlight the most important applications of FDG-PET in lymphoma, focusing on the advantages and pitfalls of this imaging, and past and ongoing efforts to standardize the use of FDG-PET, particularly in response to assessment and therapy monitoring.

Original languageEnglish
Pages (from-to)1292-1301
Number of pages10
JournalJapanese Journal of Clinical Radiology
Volume59
Issue number10
Publication statusPublished - Oct 1 2014

Fingerprint

Lymphoma
Therapeutics

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Role of FDG-PET for the treatment strategy of malignant lymphoma. / Baba, Shingo; Isoda, Takuro; Maruoka, Y.; Kitamura, Yoshiyuki; Honda, Hiroshi; Sasaki, Masayuki.

In: Japanese Journal of Clinical Radiology, Vol. 59, No. 10, 01.10.2014, p. 1292-1301.

Research output: Contribution to journalReview article

@article{5b2720dfbe554d2bb591a9b1b15b9665,
title = "Role of FDG-PET for the treatment strategy of malignant lymphoma",
abstract = "FDG-PET is increasingly being used for assessment of the staging, for evaluating the response to treatment, and for monitoring the reactions to therapy in malignant lymphoma. This review will highlight the most important applications of FDG-PET in lymphoma, focusing on the advantages and pitfalls of this imaging, and past and ongoing efforts to standardize the use of FDG-PET, particularly in response to assessment and therapy monitoring.",
author = "Shingo Baba and Takuro Isoda and Y. Maruoka and Yoshiyuki Kitamura and Hiroshi Honda and Masayuki Sasaki",
year = "2014",
month = "10",
day = "1",
language = "English",
volume = "59",
pages = "1292--1301",
journal = "Japanese Journal of Clinical Radiology",
issn = "0009-9252",
publisher = "Kanehara Shuppan Co. Ltd",
number = "10",

}

TY - JOUR

T1 - Role of FDG-PET for the treatment strategy of malignant lymphoma

AU - Baba, Shingo

AU - Isoda, Takuro

AU - Maruoka, Y.

AU - Kitamura, Yoshiyuki

AU - Honda, Hiroshi

AU - Sasaki, Masayuki

PY - 2014/10/1

Y1 - 2014/10/1

N2 - FDG-PET is increasingly being used for assessment of the staging, for evaluating the response to treatment, and for monitoring the reactions to therapy in malignant lymphoma. This review will highlight the most important applications of FDG-PET in lymphoma, focusing on the advantages and pitfalls of this imaging, and past and ongoing efforts to standardize the use of FDG-PET, particularly in response to assessment and therapy monitoring.

AB - FDG-PET is increasingly being used for assessment of the staging, for evaluating the response to treatment, and for monitoring the reactions to therapy in malignant lymphoma. This review will highlight the most important applications of FDG-PET in lymphoma, focusing on the advantages and pitfalls of this imaging, and past and ongoing efforts to standardize the use of FDG-PET, particularly in response to assessment and therapy monitoring.

UR - http://www.scopus.com/inward/record.url?scp=84908701487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908701487&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:84908701487

VL - 59

SP - 1292

EP - 1301

JO - Japanese Journal of Clinical Radiology

JF - Japanese Journal of Clinical Radiology

SN - 0009-9252

IS - 10

ER -